Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance

Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance

Item
http://www.wikidata.org/entity/Q28361569
Antimicrobial resistance: the example of Staphylococcus aureusStructure-function characterization and optimization of a plant-derived antibacterial peptide.Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in ratsActivity of and resistance to moxifloxacin in Staphylococcus aureus.Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococciLB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniaeOnce-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental modelFailure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.Kytococcus schroeteri endocarditis.Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
P2860

Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance

Item
http://www.wikidata.org/entity/Q28361569
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@ast
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@en
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@nl
type
label
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@ast
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@en
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@nl
prefLabel
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@ast
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@en
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Efficacies of moxifloxacin, ci ...... es of ciprofloxacin resistance
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.45.11.3076-3083.2001
P407
P433
P478
P577
P5875
P698
P921
P932